X-148662030-T-C
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_002025.4(AFF2):c.303T>C(p.Ser101=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000153 in 1,209,377 control chromosomes in the GnomAD database, including 2 homozygotes. There are 99 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.000089 ( 0 hom., 5 hem., cov: 22)
Exomes 𝑓: 0.00016 ( 2 hom. 94 hem. )
Consequence
AFF2
NM_002025.4 synonymous
NM_002025.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.582
Genes affected
AFF2 (HGNC:3776): (ALF transcription elongation factor 2) This gene encodes a putative transcriptional activator that is a member of the AF4\FMR2 gene family. This gene is associated with the folate-sensitive fragile X E locus on chromosome X. A repeat polymorphism in the fragile X E locus results in silencing of this gene causing Fragile X E syndrome. Fragile X E syndrome is a form of nonsyndromic X-linked cognitive disability. In addition, this gene contains 6-25 GCC repeats that are expanded to >200 repeats in the disease state. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
?
Variant X-148662030-T-C is Benign according to our data. Variant chrX-148662030-T-C is described in ClinVar as [Benign]. Clinvar id is 1336054.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
?
Synonymous conserved (PhyloP=-0.582 with no splicing effect.
BS1
?
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0000894 (10/111865) while in subpopulation SAS AF= 0.00376 (10/2662). AF 95% confidence interval is 0.00204. There are 0 homozygotes in gnomad4. There are 5 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
?
High Hemizygotes in GnomAd at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AFF2 | NM_002025.4 | c.303T>C | p.Ser101= | synonymous_variant | 3/21 | ENST00000370460.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AFF2 | ENST00000370460.7 | c.303T>C | p.Ser101= | synonymous_variant | 3/21 | 5 | NM_002025.4 | P1 | |
AFF2 | ENST00000342251.7 | c.291T>C | p.Ser97= | synonymous_variant | 3/20 | 1 | |||
AFF2 | ENST00000370457.9 | c.303T>C | p.Ser101= | synonymous_variant | 3/20 | 1 | |||
AFF2 | ENST00000370458.5 | c.291T>C | p.Ser97= | synonymous_variant | 3/8 | 1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000894 AC: 10AN: 111811Hom.: 0 Cov.: 22 AF XY: 0.000147 AC XY: 5AN XY: 33973
GnomAD3 genomes
?
AF:
AC:
10
AN:
111811
Hom.:
Cov.:
22
AF XY:
AC XY:
5
AN XY:
33973
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000387 AC: 71AN: 183487Hom.: 1 AF XY: 0.000574 AC XY: 39AN XY: 67927
GnomAD3 exomes
AF:
AC:
71
AN:
183487
Hom.:
AF XY:
AC XY:
39
AN XY:
67927
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000159 AC: 175AN: 1097512Hom.: 2 Cov.: 31 AF XY: 0.000259 AC XY: 94AN XY: 362892
GnomAD4 exome
AF:
AC:
175
AN:
1097512
Hom.:
Cov.:
31
AF XY:
AC XY:
94
AN XY:
362892
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0000894 AC: 10AN: 111865Hom.: 0 Cov.: 22 AF XY: 0.000147 AC XY: 5AN XY: 34037
GnomAD4 genome
?
AF:
AC:
10
AN:
111865
Hom.:
Cov.:
22
AF XY:
AC XY:
5
AN XY:
34037
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 05, 2017 | - - |
AFF2-related disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 15, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at